The question of whether these medications can be safely combined is important, particularly given the prevalence of both obesity and depression in the UK population
Methionine has small studies to show that it can improve metabolic disorders (such as diabetes, steatosis, and insulin resistance), decrease inflammation, and improve bone health 2
Some of these issues could be alleviated with robust human-based research, followed by FDA approval if warranted
Whats the difference between NAD+ injections and IV infusions
Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law
Injectable semaglutide and tirzepatide trials have shown average weight loss ranging from approximately 15% to 22% in different populations